DoW Melanoma Research Program Survivorship Research Award

DOD-AMRAA Posted HT942526MRPSRA

Description

Summary: The fiscal year 2026 (FY26) Melanoma Research Program (MRP) Survivorship Research Award addresses the relatively new and underfunded area of melanoma-specific survivorship by supporting a broad range of innovative and impactful research that has the intended outcome of improving the health and well-being of melanoma survivors, their families and/or their care partners in the near term. Proposed studies focusing exclusively on animal models or considering survival only without consideration of quality of life, overall health and/or function are not responsive to this funding opportunity. Distinctive Features: · The application must include at least one melanoma consumer collaborator , defined as a melanoma survivor, family member and/or care partner who can provide lived experience expertise to the research project team, or a melanoma-community supporting organization to support the planning, execution, and implementation of the proposed research. · Clinical trials are allowed.
Funding Details
Award Floor
Not specified
Award Ceiling
Not specified
Total Estimated Funding
$2,040,000.00
Expected Awards
2
Key Dates
Posted
May 21, 2026
Closes
October 14, 2026 73d
Archive Date
November 13, 2026
Agency Information
Agency Name
Defense Health Agency Contracting Activity - DHACA
Agency Code
DOD-AMRAA
Funding Instrument
Other